Literature DB >> 30266817

The ASH Agenda for Hematology Research: a roadmap for advancing scientific discovery and cures for hematologic diseases.

Charles G Mullighan1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30266817      PMCID: PMC6177655          DOI: 10.1182/bloodadvances.2018025403

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


× No keyword cloud information.
  7 in total

1.  Introduction to a review series on precision hematology.

Authors:  Benjamin L Ebert
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

2.  The ASH Agenda for Hematology Research: a roadmap for advancing scientific discovery and cures for hematologic diseases.

Authors:  Charles G Mullighan
Journal:  Blood Adv       Date:  2018-10-09

Review 3.  Welcoming a new age for gene therapy in hematology.

Authors:  Mitchell J Weiss; Charles G Mullighan
Journal:  Blood       Date:  2016-04-06       Impact factor: 22.113

4.  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Julie R Brahmer; Christina Lacchetti; Bryan J Schneider; Michael B Atkins; Kelly J Brassil; Jeffrey M Caterino; Ian Chau; Marc S Ernstoff; Jennifer M Gardner; Pamela Ginex; Sigrun Hallmeyer; Jennifer Holter Chakrabarty; Natasha B Leighl; Jennifer S Mammen; David F McDermott; Aung Naing; Loretta J Nastoupil; Tanyanika Phillips; Laura D Porter; Igor Puzanov; Cristina A Reichner; Bianca D Santomasso; Carole Seigel; Alexander Spira; Maria E Suarez-Almazor; Yinghong Wang; Jeffrey S Weber; Jedd D Wolchok; John A Thompson
Journal:  J Clin Oncol       Date:  2018-02-14       Impact factor: 44.544

5.  ClinGen--the Clinical Genome Resource.

Authors:  Heidi L Rehm; Jonathan S Berg; Lisa D Brooks; Carlos D Bustamante; James P Evans; Melissa J Landrum; David H Ledbetter; Donna R Maglott; Christa Lese Martin; Robert L Nussbaum; Sharon E Plon; Erin M Ramos; Stephen T Sherry; Michael S Watson
Journal:  N Engl J Med       Date:  2015-05-27       Impact factor: 91.245

6.  Introduction to a review series on emerging immunotherapies for hematologic diseases.

Authors:  Sophie Paczesny; Steven Z Pavletic; Catherine M Bollard
Journal:  Blood       Date:  2018-05-04       Impact factor: 22.113

7.  A call to action in hematologic disorders: A report from the ASH scientific workshop on hematology and aging.

Authors:  Ashley E Rosko; Rebecca L Olin; Andrew Artz; Tanya M Wildes; Reinhard Stauder; Heidi D Klepin
Journal:  J Geriatr Oncol       Date:  2018-05-16       Impact factor: 3.599

  7 in total
  2 in total

1.  The ASH Agenda for Hematology Research: a roadmap for advancing scientific discovery and cures for hematologic diseases.

Authors:  Charles G Mullighan
Journal:  Blood Adv       Date:  2018-10-09

Review 2.  Advances in germline predisposition to acute leukaemias and myeloid neoplasms.

Authors:  Jeffery M Klco; Charles G Mullighan
Journal:  Nat Rev Cancer       Date:  2020-12-16       Impact factor: 60.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.